Improves Metabolic Health Supports balanced blood sugar and healthy insulin function, which may help maintain steady energy
These programs typically work for commercially insured patients but not for those on government insurance
The labeled side-effect profile is the same across providers: nausea, vomiting, diarrhea, constipation, abdominal pain, and headache are common
I generally do not advise patients to discontinue abruptly, not only because of the increased risk of rebound, but also because it can cause uncontrolled sugar spikes initially, Dr
Oral GLP-1 therapies emerged as game-changers: Rybelsus (oral semaglutide) was approved for diabetes in 2019, and in December 2025 the FDA approved Wegovys first oral pill (25 mg semaglutide) for obesity ( [35] )
Role of endogenous incretin hormones, GLP-1 and GIP, in cardiovascular physiology